|
CN111269263A
|
|
Rudexilvir side chain intermediate and preparation method thereof
|
|
CN110452255A
|
|
Crystal form of Ceftriaxone Sodium and preparation method thereof
|
|
CN110483601A
|
|
Prepare β-niacinamide usp mononucleotide method and its application
|
|
CN110483553A
|
|
A kind of stable Cefuroxime Sodium and preparation method thereof
|
|
CN110437258A
|
|
The preparation method and applications of Cefuroxime Sodium
|
|
CN108117527A
|
|
A kind of I preparation method of linezolid form suitable for industrialized production
|
|
CN107935945A
|
|
A kind of method that crystal form A or crystal form D AVM hereinafter Batan products are prepared by reaction
|
|
CN107936017A
|
|
A kind of method that crystal form A or crystal form D AVM hereinafter Batan products are prepared by crystallization
|
|
CN103524508A
|
|
Imipenem-hydrate crystallization method
|
|
CN103524534A
|
|
Preparation method of flomoxef sodium
|
|
CN104418773A
|
|
Synthetic method of 2,4,5-trifluoro-benzene isocyanate and intermediate thereof
|
|
CN104418806A
|
|
Preparation method of hydrochloric acid N-demethylated bendamustine and intermediate of hydrochloric acid N-demethylated bendamustine
|
|
CN104418851A
|
|
Preparation method and purification method of quinuclidine derivatives
|
|
CN104418823A
|
|
Preparation method of febuxostat intermediate
|
|
CN104418835A
|
|
Preparation method of imatinib mesylate
|
|
CN103497096A
|
|
Refining method of 5-hydroxy tetralone
|
|
CN103113441A
|
|
Method for preparing capecitabine
|
|
CN103159783A
|
|
Aspoxicillin trihydrate refining method
|
|
CN102702253A
|
|
Method for preparing high-content creatine phosphate disodium salt
|
